58.21
-0.95(-1.61%)
Currency In USD
| Previous Close | 59.16 |
| Open | 59.03 |
| Day High | 60.14 |
| Day Low | 58.07 |
| 52-Week High | 118.21 |
| 52-Week Low | 47.25 |
| Volume | 2.28M |
| Average Volume | 1.55M |
| Market Cap | 3.96B |
| PE | 15.48 |
| EPS | 3.76 |
| Moving Average 50 Days | 71.5 |
| Moving Average 200 Days | 86.33 |
| Change | -0.95 |
If you invested $1000 in Lantheus Holdings, Inc. (LNTH) 10 years ago, it would be worth $9,511.44 as of August 24, 2025 at a share price of $58.21. Whereas If you bought $1000 worth of Lantheus Holdings, Inc. (LNTH) shares 5 years ago, it would be worth $4,340.79 as of August 24, 2025 at a share price of $58.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
GlobeNewswire Inc.
Aug 06, 2025 10:45 AM GMT
Designed to expand PSMA PET imaging access for patients by increasing batch size by ~50% and enhancing supply resiliencePDUFA date set for March 6, 2026 BEDFORD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ:
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
GlobeNewswire Inc.
Jul 23, 2025 12:00 PM GMT
BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, August 6, 2025, to discuss its financial results
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
GlobeNewswire Inc.
Jul 22, 2025 11:00 AM GMT
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. ("Life Molecula